Live Breaking News & Updates on Centre for haematology

Stay informed with the latest breaking news from Centre for haematology on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Centre for haematology and stay connected to the pulse of your community

Kadcyla Is the 'First Therapy to Show Improved Survival' in a Breast Cancer Subset

Kadcyla outperformed Herceptin regarding overall- and invasive disease-free survival in patients with HER2-positive early breast cancer that still had remaining invasive disease after undergoing neoadjuvant therapy.

San-antonio , Texas , United-states , Neu-isenburg , Hessen , Germany , German , Centre-for-haematology , Goethe-university , German-breast-group , Sibylle-loibl

Adjuvant T-DM1 Provides Sustained Survival Benefit in HER2+ Early Breast Cancer

Adjuvant ado-trastuzumab emtansine continued to improve overall survival and invasive disease-free survival vs trastuzumab after 8.4 years of follow-up in patients with HER2-positive early breast cancer and residual invasive disease following neoadjuvant therapy enrolled in the phase 3 KATHERINE trial.

San-antonio , Texas , United-states , Germany , Neu-isenburg , Hessen , German , Centre-for-haematology , German-breast-group , Goethe-university , Antonio-breast-cancer